Ischemic neurological interventional medical devices market

Ischemic Neurological Interventional Medical Devices Market, by Device Type (Neurothrombectomy Device (Aspiration/Suction Catheters, Clot Retriever , Snare-like Devices, Others), Embolization Stents, and Stenting Systems), by Procedure Type (Mechanical Thrombectomy, Carotid Endarterectomy, and Stenting), by End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Request Free Sample

Nov 2022
CMI5330
186 Pages
Excel & Pdf
Pharmaceutical

Summary

Medical devices are the electronic products which have medical use and make medical claim. The medical devices includes ultrasound products, x-ray machines, medical lasers and neurological interventional kits. Neuro-interventional devices are catheters-based, minimally-invasive approaches which are used to treat specific diseases of the blood vessels of spine, neck, head and which includes strokes, brain aneurysms, vascular malformation in brain, spine and artery diseases. The several types of Neuro-interventional devices such as flow diverters, stents, and aspiration devices are mainly used for ischemic stroke. There are mainly two types of strokes ischemic and hemorrhagic. Ischemic stroke is common type, and usually cause by blood clotting that blocks blood vessels of brain. Different Neuro-interventional devices like Aspiration device, stenting systems, clot retriever, lasers are used for diagnosis and treatment of ischemic stroke. Procedures like mechanical thrombectomy and carotid endarterectomy are the surgical procedures used to remove a build-up of fatty acid or a thrombus to improve the blood flow through face, neck and brain. As the ischemic stroke are caused by blocking of blood vessels there are several methods to prevent the stroke like controlling high blood pressure, lowering the amount of cholesterol and saturated fat in the food, managing a healthy diet and eating diet rich food like fruits and vegetables. There are different factors which are associated with higher risk of stroke like people of age 55 and above have more risk using hormone therapies can also increase the risk of ischemic stroke.

Global ischemic neurological interventional medical devices market is estimated to be valued at US$ 2,212.7 million in 2022 and is expected to exhibit a CAGR of 5.6% over the forecast period (2022-2030).

Figure 1 Global ischemic neurological interventional medical devices Market Share (%), By End User, 2022

Global Ischemic Neurological Interventional Medical Device Market- Drivers

The increasing focus on research and development by key players in order to strengthen their market presence in the global market is expected to drive growth of the global ischemic neurological interventional medical devices market over the forecast period. For instance, in October 2020, data was published by Centers for Disease Control and Prevention(CDC), according to which 1 in 6 deaths from cardiovascular disease were due to stroke. Every 40 seconds, someone in the United States has a stroke.

The increasing product launch and product approval by key players in order to strengthen their market presence in the global market is expected to drive growth of the global ischemic neurological interventional medical devices market over the forecast period. For instance, in September 2022, VESALIO, LLC., medical device company, announced the Conformitè Europëenne (CE) Mark approval for their new NeVa NET, micro-filtration technology coupled with NeVa’s Drop Zone technology creates a one-of-a-kind stent retriever, used to capture every type of clot and maximize the retention of clot for fast and effective recanalization of ischemic stroke.

Figure 2. Global ischemic neurological interventional medical devices Market Share (%), By Region, 2022

Global ischemic neurological interventional medical devices Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting production and demand of medical devices, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, are facing problems with regards to the transportation of devices from one place to another.

The COVID-19 pandemic and lockdown in various countries across the globe has negatively impacted the financial status of businesses across all sectors. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions.

The COVID-19 pandemic has a negative impact on the neurological interventional medical market. For instance, a paper was published by American Heart Association, Inc. in August, 2021, which suggested that patients with ischemic stroke and COVID 19 infection have more severe strokes while patients with vascular risk factors like diabetes, stroke, obesity, and hypertension are at increased risk of mortality and morbidity by COVID 19.

Ischemic Neurological Interventional Medical Devices Market Report Coverage

Report Coverage	Details
Base Year:	2022	Market Size in 2022:	US$ 2,212.7 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	5.6%	2030 Value Projection:	US$ 3,431.0 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Device type: Neurothrombectomy Devices, Aspiration/Suction Catheters, Clot Retrievers, Snare-like Devices, Others (Lasers etc.), Embolization Stents, Stenting System By Procedure type: Mechanical Thrombectomy, Carotid Endarterectomy, Stenting By End user: Hospitals, Specialty Clinics, Ambulatory Surgical Centers
Companies covered:	Stryker, Johnson & Johnson Private Limited., Penumbra, Inc., Medtronic, VESALIO,LLC., Sense Neuro, 880 Medical, LLC., Terumo Corporation., Imperative Care., W. L. Gore & Associate, Inc. , MicroPort Scientific Corporation., KANEKA COPORATION., Integer Holdings Corporation., Wallaby Medical.
Growth Drivers:	New developments in ischemic neurological interventional medical devices Increasing prevalence of stroke Ongoing research in ischemic neurological interventional medical devices
Restraints & Challenges:	Withdrawal and termination of trials for the medical device

Global Biopharmaceutical and Biomedicine Market: Key Developments

The increasing product launches and approvals are expected to drive the market growth over the forecast period. For instance, in April 2021, VESALIO, LLC ., a company treating stroke and vascular occlusions, initiated a clinical trial to assess the safety, performance and efficacy of NeVa stent retriever a device used to remove the thrombus in patients with ischemic stroke and will be completing the trial in December 2022.

The increasing research and development activities for the development of ischemic neurological interventional medical devices and technologies is expected to drive the market growth over the forecast period. For instance, in January 2022, STROKE: Vascular and Interventional Neurology , an article Published on behalf of the American Heart Association, Inc., and the Society of Vascular and Interventional Neurology by Wiley Periodicals LLC., focused on the paced of advancements and the anticipated trials with the results of acute ischemic stroke.

Global ischemic neurological interventional medical devices Market: Restraint

As there are different trials going on for neurological interventional devices for ischemic stroke, there are more number of premature termination and withdrawal of clinical trials due to failure of not submitting the results within specific deadline, insufficient participation of subjects, device modification, protocol amendments, etc.

For instance, in January 2020, a clinical trial of Thrombectomy device called WOLF, used to remove thrombus, for ischemic stroke was withdrawn due to poor enrollment of subject in the clinical trial. The study was designed to evaluate the safety and device technical performance of the WOLF Thrombectomy Device in removing thrombus or as an adjunct to intravenous tissue plasminogen activator (TPA) and/or to other traditional, thrombectomy modalities.

Global ischemic neurological interventional medical devices Market: Key Players

Major players operating in the global ischemic neurological interventional medical devices market include Stryker, Johnson & Johnson Private Limited., Penumbra, Inc. Medtronic, VESALIO, LLC., Sense Neuro, 880 Medical, LLC., Terumo Corporation., Imperative Care., W. L. Gore & Associate, Inc. , MicroPort Scientific Corporation., KANEKA COPORATION., Integer Holdings Corporation., Wallaby Medical.

Table of Content

Table of Contents

*Browse 30 market data tables and 28 figures on "Global Ischemic Neurological Interventional Medical Devices Market” - Global forecast to 2030

Segmentation

Detailed Segmentation:

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the global ischemic neurological interventional medical devices market during the forecast period (2022-2030)?

The global ischemic neurological interventional medical devices market size is estimated to be valued at US$ 2,212.7 million in 2022 and is expected to exhibit a CAGR of 5.6% between 2022 and 2030

What are the major factors driving the market growth?

The technological advancements and development of different neurological interventional medical devices for ischemic stroke are expected to drive the market.

Which is the leading procedure type segment in the market?

Mechanical Thrombectomy is a leading segment and is expected to hold major market share, owing to increasing product approvals and launches during the forecast period.

What are the key factors hampering growth of the market?

Major factors hampering growth of the market include termination and withdrawal of many ischemic neurological interventional medical devices clinical trials.

Which are the major players operating in the market?

Major players operating in the market include Stryker, Johnson & Johnson Private Limited., Penumbra, Inc. Medtronic, VESALIO, LLC., Sense Neuro, 880 Medical, LLC., Terumo Corporation., Imperative Care., W. L. Gore & Associate, Inc. , MicroPort Scientific Corporation., KANEKA COPORATION., Integer Holdings Corporation., Wallaby Medical.